Depression, Anxiety and Sleep in Parkinson's Disease
ConditionParkinson's Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50+
SponsorSohag University
About this trial
This study aims to assess the prevalence and severity of depression, anxiety, and sleep disorders among patients with idiopathic Parkinson's disease. The study will evaluate the relationship between neuropsychiatric symptoms and disease characteristics in order to improve early recognition and patient quality of life.
Eligibility criteria
Qualifiers
Patients diagnosed with idiopathic Parkinson's disease according to the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's Disease (Postuma et al., 2015).
Age ≥ 50 years.
Ability to understand and respond to questionnaires and rating scales.
Ability and willingness to provide informed consent.
Disqualifiers
Patients with atypical parkinsonism.
Patients with a history of other major neurological disorders (e.g., stroke, Alzheimer's disease, multiple sclerosis).
Patients with severe cognitive impairment or dementia that prevents reliable completion of rating scales.
Patients with a current diagnosis of severe psychiatric disorders unrelated to 5-Parkinson's disease (e.g., schizophrenia, bipolar disorder).
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
This trial has no locations
Sponsors and collaborators
Sohag University
Lead sponsor
Source ClinicalTrials.gov